Navigation Links
Cutanea Announces Promising Phase II Results in Rosacea with Omiganan
Date:10/17/2007

p=0.012 for per protocol populations). While in this exploratory study this endpoint was identified as a secondary end point, FDA currently requires the absolute change (rather than percent change) in the number of inflammatory lesions as one of the co-primary endpoints, along with Treatment Success, for demonstrating efficacy in a Phase III trial in rosacea.

"Based on these encouraging results, we have selected once-daily Omiganan 2.5% for further study in rosacea, which is a critical step towards potential commercialization, either directly or in collaboration with a partner," commented Robert J. Bitterman, President and CEO of Cutanea.

About Rosacea

Rosacea is a chronic dermatologic disorder with no current cure and a poorly understood etiology that afflicts an estimated 14 million Americans. Symptoms primarily manifest on the facial skin and include facial flushing, central facial inflammatory lesions, and facial erythema. According to surveys conducted by the National Rosacea Society (NRS), nearly 70% of rosacea patients said the disorder had lowered their self-confidence and self-esteem; 41% reported it had caused them to avoid public contact or cancel social engagements; and nearly 30% claimed to have missed work due to rosacea. Of these rosacea patients surveyed by the NRS that sought medical treatment, over 70 percent reported an improvement in their emotional and social well-being.

Typical onset of rosacea occurs between 30 and 50 years of age and is more prevalent in women than men. Clearing up the initial outbreak is only the beginning, as rosacea is characterized by periods of relapses and remissions. Relapse episodes can be spurred by sun exposure, stress, hot or cold weather, alcohol, spicy foods, exercise, and certain skin care products and medications.

Absent a cure for rosacea, treatment is aimed at alleviating the disorder's symptoms. Topical or oral medications are generally prescribed for mild to moderate papulopus
'/>"/>

SOURCE Cutanea Life Sciences
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Md. , May 22, 2015  RegeneRx Biopharmaceuticals, ... on tissue protection, repair and regeneration, today announced that ... is scheduled to present a corporate overview at two ... present at the SeeThruEquity 4 th Annual Microcap ... New York City at 11:00 am EDT. ...
(Date:5/22/2015)... , May 22, 2015  The Mesothelioma ... diagnosed victims of mesothelioma get the best possible ... certain individuals with this rare cancer caused by ... most up-to-date information related to treatment options such ... please call the Mesothelioma Victims Center anytime at ...
(Date:5/22/2015)... , May 22, 2015 Research and Markets ... addition of the "Latest Regulations on Pharmaceutical ... to their offering. This is first ... a guidance on international multi-center clinical trials of ... has begun to be implemented on March 1, ...
Breaking Medicine Technology:RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 52015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
... CALGARY, Alberta, July 27, 2011 Fero Industries, Inc. ... Merck S.A. de C.V. has increased its Sucanon® promotional ...  Four tablet sample packages of Sucanon® will be provided ... to raise awareness and encourage long-term customer acceptance of ...
... VALLEY, Md., July 27, 2011 Pharmaceutics International, Inc. ... announced  that it has added hot melt extrusion (HME) ... The company has purchased a 16mm and an 18mm ... carry out feasibility studies, using just a few grams ...
Cached Medicine Technology:Fero Industries Increases Sucanon® Promotion in Mexico with Physician Distributed Sample Packages 2Fero Industries Increases Sucanon® Promotion in Mexico with Physician Distributed Sample Packages 3Pharmaceutics International, Inc. (Pii) Expands Drug Formulation and Manufacturing Capabilities with Hot Melt Extrusion Technology 2
(Date:5/22/2015)... Pioneer Millworks, the largest reclaimed wood ... designing with reclaimed wood, introducing their latest reclaimed wood ... Their newest offerings, Vat 35, Reclaimed Teak , ... to America's largest design event. , “Designers, architects, builders, ... anxious to see and feel the variety of wood ...
(Date:5/22/2015)... 2015 Following yesterday’s announcement that Ascenta ... US-based health brand Nature’s Way, Marc St-Onge has affirmed ... Ascenta Skin is an integral part of the agreement ... opportunity to further develop Ascenta Skin into a leading ... is a breakthrough, anti-aging skincare supplement featuring 6 active ...
(Date:5/22/2015)... Washington, DC (PRWEB) May 22, 2015 ... Howard University Hospital’s world-renowned surgical oncologist, Dr. LaSalle D. ... celebration. , The luncheon began after Grand Rounds in ... Delores Leffall, waited anxiously outside the auditorium, trying to ... hear him, but if he sees me, he’ll know ...
(Date:5/22/2015)... May 22, 2015 Power Systems is proud ... the 2015 race season. Drobeck is in his second year ... a firefighter with the Missoula Fire Department in Missoula, MT. ... Pro in 2014. During his career, he has had 15 ... Drobeck recorded top 10 finishes in all seven of his ...
(Date:5/22/2015)... Building Concepts is experienced with all forms of interior ... include decks, additions, kitchen remodeling, interior renovations, exterior renovations, ... , The redesigned logo is a fresh modern look ... two geometrical lines that represent the engineering aspect in ... with many things associated with the company. The new ...
Breaking Medicine News(10 mins):Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 3Health News:Ascenta Skin President Announces Plans to Grow Brand 2Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2
... finest local physicians for new ... Chicago practice, BELLEVUE, ... Chicago practice with two of the,area,s finest primary care physicians. With 30 ... for the company to seek its,next two physicians and expand its network., ...
... nation,s,leading association for professionally managed assisted living companies,today ... of life choices,made by aging Americans., Richard ... Living Federation,of America (ALFA), said the assisted living ... in testimony submitted to the Senate Special,Committee on ...
... An Average Of $3,354 Annually Toward Family Coverage, More,Than ... Shares of Workers Now Face Deductibles Of At Least ... By Smaller Firms, WASHINGTON, Sept. 24 Premiums ... this year -- with employees on average paying $3,354 ...
... Modern cancer care is critically dependent on imaging ... and guide their therapy or surgery. Molecular imaging ... characteristics of malignancies, tumor stage and therapeutical response, ... assess the tumor,s anatomical or morphologic features including ...
... but often life-threatening cause of massive gastrointestinal bleeding. PAEFs ... absence of surgical intervention, and in most case, the ... such case wherein the cause of death was PAEF-induced ... patient from the hospital. Few previous reports on PAEF ...
... focused on cancer therapy, announced today that ... Corporation Sdn Bhd (BiotechCorp), will initially focus ... and drug delivery systems for tropical diseases, ... exclusive, global license to a Nanobiotix nanotechnology ...
Cached Medicine News:Health News:MD2 International Brings Highly Attentive Medicine to Chicago 2Health News:ALFA Honors End of Life Choices 2Health News:Yearly Premiums for Family Health Coverage Rise to $12,680 in 2008, Up 5 Percent, As Many Workers Also Face Higher Deductibles 2Health News:Yearly Premiums for Family Health Coverage Rise to $12,680 in 2008, Up 5 Percent, As Many Workers Also Face Higher Deductibles 3Health News:Yearly Premiums for Family Health Coverage Rise to $12,680 in 2008, Up 5 Percent, As Many Workers Also Face Higher Deductibles 4Health News:Yearly Premiums for Family Health Coverage Rise to $12,680 in 2008, Up 5 Percent, As Many Workers Also Face Higher Deductibles 5Health News:Yearly Premiums for Family Health Coverage Rise to $12,680 in 2008, Up 5 Percent, As Many Workers Also Face Higher Deductibles 6Health News:Yearly Premiums for Family Health Coverage Rise to $12,680 in 2008, Up 5 Percent, As Many Workers Also Face Higher Deductibles 7Health News:Yearly Premiums for Family Health Coverage Rise to $12,680 in 2008, Up 5 Percent, As Many Workers Also Face Higher Deductibles 8Health News:What is the clinical features of primary aortoenteric fistula? 2Health News: Nanobiotix and BiotechCorp Announce Initial Focus of Their Collaboration: P-O-C Diagnostics and Drug Delivery Systems for Tropical Diseases, Such as Malaria 2Health News: Nanobiotix and BiotechCorp Announce Initial Focus of Their Collaboration: P-O-C Diagnostics and Drug Delivery Systems for Tropical Diseases, Such as Malaria 3
... offering of single-use instruments on the market., Available ... for Bariatric Surgery. , Dual action tips ... the pivot points to reduce the chance of ... cord, which eliminates gapping at connection and the ...
... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Medicine Products: